AustralieFrV1, PascalFrancis, Corpus, bibRecord, 000758

Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium

Identifieur interne : 000758 ( PascalFrancis/Corpus ); précédent : 000757; suivant : 000759

Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium

Auteurs : Elizabeth Milne ; Kathryn R. Greenop ; Catherine Metayer ; Joachim Schüz ; Eleni Petridou ; Maria S. Pombo-De-Oliveira ; Claire Infante-Rivard ; Eve Roman ; John D. Dockerty ; Logan G. Spector ; Sérgio Koifman ; Laurent Orsi ; Jérémie Rudant ; Nick Dessypris ; Jill Simpson ; Tracy Lightfoot ; Peter Kaatsch ; Margarita Baka ; Alessandra Faro ; Bruce K. Armstrong ; Jacqueline Clavel ; Patricia A. Buffler

Source :

International journal of cancer : (Print) [ 0020-7136 ] ; 2013.

RBID : Pascal:13-0338338

Descripteurs français

Pascal (Inist)
- Foetus, Croissance, Enfant, Leucémie aiguë lymphoblastique, Poids naissance, Métaanalyse, Cancérologie.

English descriptors

KwdEn :
- Acute lymphocytic leukemia, Birth weight, Cancerology, Child, Fetus, Growth, Metaanalysis.

Abstract

Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0020-7136`
A02	`01`			`@0 IJCNAW`
A03		`1`		`@0 Int. j. cancer : (Print)`
A05				`@2 133`
A06				`@2 12`
A08	`01`	`1`	`ENG`	`@1 Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium`
A11	`01`	`1`		`@1 MILNE (Elizabeth)`
A11	`02`	`1`		`@1 GREENOP (Kathryn R.)`
A11	`03`	`1`		`@1 METAYER (Catherine)`
A11	`04`	`1`		`@1 SCHÜZ (Joachim)`
A11	`05`	`1`		`@1 PETRIDOU (Eleni)`
A11	`06`	`1`		`@1 POMBO-DE-OLIVEIRA (Maria S.)`
A11	`07`	`1`		`@1 INFANTE-RIVARD (Claire)`
A11	`08`	`1`		`@1 ROMAN (Eve)`
A11	`09`	`1`		`@1 DOCKERTY (John D.)`
A11	`10`	`1`		`@1 SPECTOR (Logan G.)`
A11	`11`	`1`		`@1 KOIFMAN (Sérgio)`
A11	`12`	`1`		`@1 ORSI (Laurent)`
A11	`13`	`1`		`@1 RUDANT (Jérémie)`
A11	`14`	`1`		`@1 DESSYPRIS (Nick)`
A11	`15`	`1`		`@1 SIMPSON (Jill)`
A11	`16`	`1`		`@1 LIGHTFOOT (Tracy)`
A11	`17`	`1`		`@1 KAATSCH (Peter)`
A11	`18`	`1`		`@1 BAKA (Margarita)`
A11	`19`	`1`		`@1 FARO (Alessandra)`
A11	`20`	`1`		`@1 ARMSTRONG (Bruce K.)`
A11	`21`	`1`		`@1 CLAVEL (Jacqueline)`
A11	`22`	`1`		`@1 BUFFLER (Patricia A.)`
A14	`01`			`@1 Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia @2 WA @3 AUS @Z 1 aut. @Z 2 aut.`
A14	`02`			`@1 School of Public Health, University of California, Berkeley @2 Berkeley, CA @3 USA @Z 3 aut. @Z 22 aut.`
A14	`03`			`@1 Section of Environment and Radiation, International Agency for Research on Cancer (IARC) @2 Lyon @3 FRA @Z 4 aut.`
A14	`04`			`@1 Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens @2 Athens @3 GRC @Z 5 aut. @Z 14 aut.`
A14	`05`			`@1 Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer @2 Rio de Janeiro @3 BRA @Z 6 aut. @Z 19 aut.`
A14	`06`			`@1 Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University @2 Montréal, QC @3 CAN @Z 7 aut.`
A14	`07`			`@1 Department of Health Science, University of York @2 York @3 GBR @Z 8 aut. @Z 15 aut. @Z 16 aut.`
A14	`08`			`@1 Dean's Department, Dunedin School of Medicine, University of Otago @2 Dunedin @3 NZL @Z 9 aut.`
A14	`09`			`@1 Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago @2 Dunedin @3 NZL @Z 9 aut.`
A14	`10`			`@1 Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota @2 Minneapolis, MN @3 USA @Z 10 aut.`
A14	`11`			`@1 Department of Pediatrics, Masonic Cancer Center, University of Minnesota @2 Minneapolis, MN @3 USA @Z 10 aut.`
A14	`12`			`@1 National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health @2 Rio de Janeiro @3 BRA @Z 11 aut.`
A14	`13`			`@1 INSERM U1018, CESP Villejuif @3 FRA @Z 12 aut. @Z 13 aut. @Z 21 aut.`
A14	`14`			`@1 Université Paris-Sud, UMRS 1018 @2 Villejuif @3 FRA @Z 12 aut. @Z 13 aut. @Z 21 aut.`
A14	`15`			`@1 National Registry of Childhood Hematopoietic Malignancies @2 Villejuif @3 FRA @Z 13 aut. @Z 21 aut.`
A14	`16`			`@1 German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz @2 Mainz @3 DEU @Z 17 aut.`
A14	`17`			`@1 Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital @2 Athens @3 GRC @Z 18 aut.`
A14	`18`			`@1 Sydney School of Public Health, University of Sydney @2 NSW @3 AUS @Z 20 aut.`
A17	`01`	`1`		`@1 Aus-ALL Consortium @3 AUS`
A20				`@1 2968-2979`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 13027 @5 354000501579740220`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 13-0338338`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 International journal of cancer : (Print)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.
C02	`01`	`X`		`@0 002B04`
C02	`02`	`X`		`@0 002B19B`
C03	`01`	`X`	`FRE`	`@0 Foetus @5 02`
C03	`01`	`X`	`ENG`	`@0 Fetus @5 02`
C03	`01`	`X`	`SPA`	`@0 Feto @5 02`
C03	`02`	`X`	`FRE`	`@0 Croissance @5 03`
C03	`02`	`X`	`ENG`	`@0 Growth @5 03`
C03	`02`	`X`	`SPA`	`@0 Crecimiento @5 03`
C03	`03`	`X`	`FRE`	`@0 Enfant @5 05`
C03	`03`	`X`	`ENG`	`@0 Child @5 05`
C03	`03`	`X`	`SPA`	`@0 Niño @5 05`
C03	`04`	`X`	`FRE`	`@0 Leucémie aiguë lymphoblastique @5 06`
C03	`04`	`X`	`ENG`	`@0 Acute lymphocytic leukemia @5 06`
C03	`04`	`X`	`SPA`	`@0 Leucemia aguda linfoblástica @5 06`
C03	`05`	`X`	`FRE`	`@0 Poids naissance @5 09`
C03	`05`	`X`	`ENG`	`@0 Birth weight @5 09`
C03	`05`	`X`	`SPA`	`@0 Peso nacimiento @5 09`
C03	`06`	`X`	`FRE`	`@0 Métaanalyse @5 11`
C03	`06`	`X`	`ENG`	`@0 Metaanalysis @5 11`
C03	`06`	`X`	`SPA`	`@0 Meta-análisis @5 11`
C03	`07`	`X`	`FRE`	`@0 Cancérologie @5 12`
C03	`07`	`X`	`ENG`	`@0 Cancerology @5 12`
C03	`07`	`X`	`SPA`	`@0 Cancerología @5 12`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Hémopathie maligne @2 NM @5 37`
C07	`02`	`X`	`ENG`	`@0 Malignant hemopathy @2 NM @5 37`
C07	`02`	`X`	`SPA`	`@0 Hemopatía maligna @2 NM @5 37`
C07	`03`	`X`	`FRE`	`@0 Cancer @2 NM`
C07	`03`	`X`	`ENG`	`@0 Cancer @2 NM`
C07	`03`	`X`	`SPA`	`@0 Cáncer @2 NM`
C07	`04`	`X`	`FRE`	`@0 Syndrome lymphoprolifératif @2 NM @5 38`
C07	`04`	`X`	`ENG`	`@0 Lymphoproliferative syndrome @2 NM @5 38`
C07	`04`	`X`	`SPA`	`@0 Linfoproliferativo síndrome @2 NM @5 38`
N21				`@1 322`

Format Inist (serveur)

NO :	PASCAL 13-0338338 INIST
ET :	Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium
AU :	MILNE (Elizabeth); GREENOP (Kathryn R.); METAYER (Catherine); SCHÜZ (Joachim); PETRIDOU (Eleni); POMBO-DE-OLIVEIRA (Maria S.); INFANTE-RIVARD (Claire); ROMAN (Eve); DOCKERTY (John D.); SPECTOR (Logan G.); KOIFMAN (Sérgio); ORSI (Laurent); RUDANT (Jérémie); DESSYPRIS (Nick); SIMPSON (Jill); LIGHTFOOT (Tracy); KAATSCH (Peter); BAKA (Margarita); FARO (Alessandra); ARMSTRONG (Bruce K.); CLAVEL (Jacqueline); BUFFLER (Patricia A.)
AF :	Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia/WA/Australie (1 aut., 2 aut.); School of Public Health, University of California, Berkeley/Berkeley, CA/Etats-Unis (3 aut., 22 aut.); Section of Environment and Radiation, International Agency for Research on Cancer (IARC)/Lyon/France (4 aut.); Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens/Athens/Grèce (5 aut., 14 aut.); Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer/Rio de Janeiro/Brésil (6 aut., 19 aut.); Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University/Montréal, QC/Canada (7 aut.); Department of Health Science, University of York/York/Royaume-Uni (8 aut., 15 aut., 16 aut.); Dean's Department, Dunedin School of Medicine, University of Otago/Dunedin/Nouvelle-Zélande (9 aut.); Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago/Dunedin/Nouvelle-Zélande (9 aut.); Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota/Minneapolis, MN/Etats-Unis (10 aut.); Department of Pediatrics, Masonic Cancer Center, University of Minnesota/Minneapolis, MN/Etats-Unis (10 aut.); National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health/Rio de Janeiro/Brésil (11 aut.); INSERM U1018, CESP Villejuif/France (12 aut., 13 aut., 21 aut.); Université Paris-Sud, UMRS 1018/Villejuif/France (12 aut., 13 aut., 21 aut.); National Registry of Childhood Hematopoietic Malignancies/Villejuif/France (13 aut., 21 aut.); German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz/Mainz/Allemagne (17 aut.); Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital/Athens/Grèce (18 aut.); Sydney School of Public Health, University of Sydney/NSW/Australie (20 aut.)
DT :	Publication en série; Niveau analytique
SO :	International journal of cancer : (Print); ISSN 0020-7136; Coden IJCNAW; Etats-Unis; Da. 2013; Vol. 133; No. 12; Pp. 2968-2979; Bibl. 35 ref.
LA :	Anglais
EA :	Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.
CC :	002B04; 002B19B
FD :	Foetus; Croissance; Enfant; Leucémie aiguë lymphoblastique; Poids naissance; Métaanalyse; Cancérologie
FG :	Homme; Hémopathie maligne; Cancer; Syndrome lymphoprolifératif
ED :	Fetus; Growth; Child; Acute lymphocytic leukemia; Birth weight; Metaanalysis; Cancerology
EG :	Human; Malignant hemopathy; Cancer; Lymphoproliferative syndrome
SD :	Feto; Crecimiento; Niño; Leucemia aguda linfoblástica; Peso nacimiento; Meta-análisis; Cancerología
LO :	INIST-13027.354000501579740220
ID :	13-0338338

Links to Exploration step

Pascal:13-0338338

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium</title>
<author><name sortKey="Milne, Elizabeth" sort="Milne, Elizabeth" uniqKey="Milne E" first="Elizabeth" last="Milne">Elizabeth Milne</name>
<affiliation><inist:fA14 i1="01"><s1>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia</s1>
<s2>WA</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Greenop, Kathryn R" sort="Greenop, Kathryn R" uniqKey="Greenop K" first="Kathryn R." last="Greenop">Kathryn R. Greenop</name>
<affiliation><inist:fA14 i1="01"><s1>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia</s1>
<s2>WA</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Metayer, Catherine" sort="Metayer, Catherine" uniqKey="Metayer C" first="Catherine" last="Metayer">Catherine Metayer</name>
<affiliation><inist:fA14 i1="02"><s1>School of Public Health, University of California, Berkeley</s1>
<s2>Berkeley, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schuz, Joachim" sort="Schuz, Joachim" uniqKey="Schuz J" first="Joachim" last="Schüz">Joachim Schüz</name>
<affiliation><inist:fA14 i1="03"><s1>Section of Environment and Radiation, International Agency for Research on Cancer (IARC)</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petridou, Eleni" sort="Petridou, Eleni" uniqKey="Petridou E" first="Eleni" last="Petridou">Eleni Petridou</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pombo De Oliveira, Maria S" sort="Pombo De Oliveira, Maria S" uniqKey="Pombo De Oliveira M" first="Maria S." last="Pombo-De-Oliveira">Maria S. Pombo-De-Oliveira</name>
<affiliation><inist:fA14 i1="05"><s1>Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Infante Rivard, Claire" sort="Infante Rivard, Claire" uniqKey="Infante Rivard C" first="Claire" last="Infante-Rivard">Claire Infante-Rivard</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University</s1>
<s2>Montréal, QC</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roman, Eve" sort="Roman, Eve" uniqKey="Roman E" first="Eve" last="Roman">Eve Roman</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dockerty, John D" sort="Dockerty, John D" uniqKey="Dockerty J" first="John D." last="Dockerty">John D. Dockerty</name>
<affiliation><inist:fA14 i1="08"><s1>Dean's Department, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="09"><s1>Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Spector, Logan G" sort="Spector, Logan G" uniqKey="Spector L" first="Logan G." last="Spector">Logan G. Spector</name>
<affiliation><inist:fA14 i1="10"><s1>Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>Department of Pediatrics, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Koifman, Sergio" sort="Koifman, Sergio" uniqKey="Koifman S" first="Sérgio" last="Koifman">Sérgio Koifman</name>
<affiliation><inist:fA14 i1="12"><s1>National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orsi, Laurent" sort="Orsi, Laurent" uniqKey="Orsi L" first="Laurent" last="Orsi">Laurent Orsi</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rudant, Jeremie" sort="Rudant, Jeremie" uniqKey="Rudant J" first="Jérémie" last="Rudant">Jérémie Rudant</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="15"><s1>National Registry of Childhood Hematopoietic Malignancies</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dessypris, Nick" sort="Dessypris, Nick" uniqKey="Dessypris N" first="Nick" last="Dessypris">Nick Dessypris</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Simpson, Jill" sort="Simpson, Jill" uniqKey="Simpson J" first="Jill" last="Simpson">Jill Simpson</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lightfoot, Tracy" sort="Lightfoot, Tracy" uniqKey="Lightfoot T" first="Tracy" last="Lightfoot">Tracy Lightfoot</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaatsch, Peter" sort="Kaatsch, Peter" uniqKey="Kaatsch P" first="Peter" last="Kaatsch">Peter Kaatsch</name>
<affiliation><inist:fA14 i1="16"><s1>German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz</s1>
<s2>Mainz</s2>
<s3>DEU</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Baka, Margarita" sort="Baka, Margarita" uniqKey="Baka M" first="Margarita" last="Baka">Margarita Baka</name>
<affiliation><inist:fA14 i1="17"><s1>Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Faro, Alessandra" sort="Faro, Alessandra" uniqKey="Faro A" first="Alessandra" last="Faro">Alessandra Faro</name>
<affiliation><inist:fA14 i1="05"><s1>Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Armstrong, Bruce K" sort="Armstrong, Bruce K" uniqKey="Armstrong B" first="Bruce K." last="Armstrong">Bruce K. Armstrong</name>
<affiliation><inist:fA14 i1="18"><s1>Sydney School of Public Health, University of Sydney</s1>
<s2>NSW</s2>
<s3>AUS</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Clavel, Jacqueline" sort="Clavel, Jacqueline" uniqKey="Clavel J" first="Jacqueline" last="Clavel">Jacqueline Clavel</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="15"><s1>National Registry of Childhood Hematopoietic Malignancies</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Buffler, Patricia A" sort="Buffler, Patricia A" uniqKey="Buffler P" first="Patricia A." last="Buffler">Patricia A. Buffler</name>
<affiliation><inist:fA14 i1="02"><s1>School of Public Health, University of California, Berkeley</s1>
<s2>Berkeley, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0338338</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0338338 INIST</idno>
<idno type="RBID">Pascal:13-0338338</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000758</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium</title>
<author><name sortKey="Milne, Elizabeth" sort="Milne, Elizabeth" uniqKey="Milne E" first="Elizabeth" last="Milne">Elizabeth Milne</name>
<affiliation><inist:fA14 i1="01"><s1>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia</s1>
<s2>WA</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Greenop, Kathryn R" sort="Greenop, Kathryn R" uniqKey="Greenop K" first="Kathryn R." last="Greenop">Kathryn R. Greenop</name>
<affiliation><inist:fA14 i1="01"><s1>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia</s1>
<s2>WA</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Metayer, Catherine" sort="Metayer, Catherine" uniqKey="Metayer C" first="Catherine" last="Metayer">Catherine Metayer</name>
<affiliation><inist:fA14 i1="02"><s1>School of Public Health, University of California, Berkeley</s1>
<s2>Berkeley, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schuz, Joachim" sort="Schuz, Joachim" uniqKey="Schuz J" first="Joachim" last="Schüz">Joachim Schüz</name>
<affiliation><inist:fA14 i1="03"><s1>Section of Environment and Radiation, International Agency for Research on Cancer (IARC)</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petridou, Eleni" sort="Petridou, Eleni" uniqKey="Petridou E" first="Eleni" last="Petridou">Eleni Petridou</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pombo De Oliveira, Maria S" sort="Pombo De Oliveira, Maria S" uniqKey="Pombo De Oliveira M" first="Maria S." last="Pombo-De-Oliveira">Maria S. Pombo-De-Oliveira</name>
<affiliation><inist:fA14 i1="05"><s1>Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Infante Rivard, Claire" sort="Infante Rivard, Claire" uniqKey="Infante Rivard C" first="Claire" last="Infante-Rivard">Claire Infante-Rivard</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University</s1>
<s2>Montréal, QC</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Roman, Eve" sort="Roman, Eve" uniqKey="Roman E" first="Eve" last="Roman">Eve Roman</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dockerty, John D" sort="Dockerty, John D" uniqKey="Dockerty J" first="John D." last="Dockerty">John D. Dockerty</name>
<affiliation><inist:fA14 i1="08"><s1>Dean's Department, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="09"><s1>Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Spector, Logan G" sort="Spector, Logan G" uniqKey="Spector L" first="Logan G." last="Spector">Logan G. Spector</name>
<affiliation><inist:fA14 i1="10"><s1>Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>Department of Pediatrics, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Koifman, Sergio" sort="Koifman, Sergio" uniqKey="Koifman S" first="Sérgio" last="Koifman">Sérgio Koifman</name>
<affiliation><inist:fA14 i1="12"><s1>National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orsi, Laurent" sort="Orsi, Laurent" uniqKey="Orsi L" first="Laurent" last="Orsi">Laurent Orsi</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rudant, Jeremie" sort="Rudant, Jeremie" uniqKey="Rudant J" first="Jérémie" last="Rudant">Jérémie Rudant</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="15"><s1>National Registry of Childhood Hematopoietic Malignancies</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dessypris, Nick" sort="Dessypris, Nick" uniqKey="Dessypris N" first="Nick" last="Dessypris">Nick Dessypris</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Simpson, Jill" sort="Simpson, Jill" uniqKey="Simpson J" first="Jill" last="Simpson">Jill Simpson</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lightfoot, Tracy" sort="Lightfoot, Tracy" uniqKey="Lightfoot T" first="Tracy" last="Lightfoot">Tracy Lightfoot</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaatsch, Peter" sort="Kaatsch, Peter" uniqKey="Kaatsch P" first="Peter" last="Kaatsch">Peter Kaatsch</name>
<affiliation><inist:fA14 i1="16"><s1>German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz</s1>
<s2>Mainz</s2>
<s3>DEU</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Baka, Margarita" sort="Baka, Margarita" uniqKey="Baka M" first="Margarita" last="Baka">Margarita Baka</name>
<affiliation><inist:fA14 i1="17"><s1>Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Faro, Alessandra" sort="Faro, Alessandra" uniqKey="Faro A" first="Alessandra" last="Faro">Alessandra Faro</name>
<affiliation><inist:fA14 i1="05"><s1>Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Armstrong, Bruce K" sort="Armstrong, Bruce K" uniqKey="Armstrong B" first="Bruce K." last="Armstrong">Bruce K. Armstrong</name>
<affiliation><inist:fA14 i1="18"><s1>Sydney School of Public Health, University of Sydney</s1>
<s2>NSW</s2>
<s3>AUS</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Clavel, Jacqueline" sort="Clavel, Jacqueline" uniqKey="Clavel J" first="Jacqueline" last="Clavel">Jacqueline Clavel</name>
<affiliation><inist:fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="15"><s1>National Registry of Childhood Hematopoietic Malignancies</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Buffler, Patricia A" sort="Buffler, Patricia A" uniqKey="Buffler P" first="Patricia A." last="Buffler">Patricia A. Buffler</name>
<affiliation><inist:fA14 i1="02"><s1>School of Public Health, University of California, Berkeley</s1>
<s2>Berkeley, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal of cancer : (Print)</title>
<title level="j" type="abbreviated">Int. j. cancer : (Print)</title>
<idno type="ISSN">0020-7136</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of cancer : (Print)</title>
<title level="j" type="abbreviated">Int. j. cancer : (Print)</title>
<idno type="ISSN">0020-7136</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute lymphocytic leukemia</term>
<term>Birth weight</term>
<term>Cancerology</term>
<term>Child</term>
<term>Fetus</term>
<term>Growth</term>
<term>Metaanalysis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Foetus</term>
<term>Croissance</term>
<term>Enfant</term>
<term>Leucémie aiguë lymphoblastique</term>
<term>Poids naissance</term>
<term>Métaanalyse</term>
<term>Cancérologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0020-7136</s0>
</fA01>
<fA02 i1="01"><s0>IJCNAW</s0>
</fA02>
<fA03 i2="1"><s0>Int. j. cancer : (Print)</s0>
</fA03>
<fA05><s2>133</s2>
</fA05>
<fA06><s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MILNE (Elizabeth)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GREENOP (Kathryn R.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>METAYER (Catherine)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SCHÜZ (Joachim)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PETRIDOU (Eleni)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>POMBO-DE-OLIVEIRA (Maria S.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>INFANTE-RIVARD (Claire)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>ROMAN (Eve)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DOCKERTY (John D.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>SPECTOR (Logan G.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>KOIFMAN (Sérgio)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>ORSI (Laurent)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>RUDANT (Jérémie)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>DESSYPRIS (Nick)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>SIMPSON (Jill)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>LIGHTFOOT (Tracy)</s1>
</fA11>
<fA11 i1="17" i2="1"><s1>KAATSCH (Peter)</s1>
</fA11>
<fA11 i1="18" i2="1"><s1>BAKA (Margarita)</s1>
</fA11>
<fA11 i1="19" i2="1"><s1>FARO (Alessandra)</s1>
</fA11>
<fA11 i1="20" i2="1"><s1>ARMSTRONG (Bruce K.)</s1>
</fA11>
<fA11 i1="21" i2="1"><s1>CLAVEL (Jacqueline)</s1>
</fA11>
<fA11 i1="22" i2="1"><s1>BUFFLER (Patricia A.)</s1>
</fA11>
<fA14 i1="01"><s1>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia</s1>
<s2>WA</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>School of Public Health, University of California, Berkeley</s1>
<s2>Berkeley, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Section of Environment and Radiation, International Agency for Research on Cancer (IARC)</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>5 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>6 aut.</sZ>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University</s1>
<s2>Montréal, QC</s2>
<s3>CAN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Health Science, University of York</s1>
<s2>York</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Dean's Department, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago</s1>
<s2>Dunedin</s2>
<s3>NZL</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Department of Pediatrics, Masonic Cancer Center, University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health</s1>
<s2>Rio de Janeiro</s2>
<s3>BRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>INSERM U1018, CESP Villejuif</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Université Paris-Sud, UMRS 1018</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>National Registry of Childhood Hematopoietic Malignancies</s1>
<s2>Villejuif</s2>
<s3>FRA</s3>
<sZ>13 aut.</sZ>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz</s1>
<s2>Mainz</s2>
<s3>DEU</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital</s1>
<s2>Athens</s2>
<s3>GRC</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>Sydney School of Public Health, University of Sydney</s1>
<s2>NSW</s2>
<s3>AUS</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1"><s1>Aus-ALL Consortium</s1>
<s3>AUS</s3>
</fA17>
<fA20><s1>2968-2979</s1>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>13027</s2>
<s5>354000501579740220</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0338338</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal of cancer : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B04</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B19B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Foetus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Fetus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Feto</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Croissance</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Growth</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Crecimiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Enfant</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Child</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Niño</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Leucémie aiguë lymphoblastique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Acute lymphocytic leukemia</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Leucemia aguda linfoblástica</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Poids naissance</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Birth weight</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Peso nacimiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Métaanalyse</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Metaanalysis</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Meta-análisis</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Cancérologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Cancerology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cancerología</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Hémopathie maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Malignant hemopathy</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Hemopatía maligna</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Syndrome lymphoprolifératif</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lymphoproliferative syndrome</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Linfoproliferativo síndrome</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fN21><s1>322</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 13-0338338 INIST</NO>
<ET>Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium</ET>
<AU>MILNE (Elizabeth); GREENOP (Kathryn R.); METAYER (Catherine); SCHÜZ (Joachim); PETRIDOU (Eleni); POMBO-DE-OLIVEIRA (Maria S.); INFANTE-RIVARD (Claire); ROMAN (Eve); DOCKERTY (John D.); SPECTOR (Logan G.); KOIFMAN (Sérgio); ORSI (Laurent); RUDANT (Jérémie); DESSYPRIS (Nick); SIMPSON (Jill); LIGHTFOOT (Tracy); KAATSCH (Peter); BAKA (Margarita); FARO (Alessandra); ARMSTRONG (Bruce K.); CLAVEL (Jacqueline); BUFFLER (Patricia A.)</AU>
<AF>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia/WA/Australie (1 aut., 2 aut.); School of Public Health, University of California, Berkeley/Berkeley, CA/Etats-Unis (3 aut., 22 aut.); Section of Environment and Radiation, International Agency for Research on Cancer (IARC)/Lyon/France (4 aut.); Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens/Athens/Grèce (5 aut., 14 aut.); Pediatric Hematology-Oncology Program, Research Program, Instituto Nacional de Cancer/Rio de Janeiro/Brésil (6 aut., 19 aut.); Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University/Montréal, QC/Canada (7 aut.); Department of Health Science, University of York/York/Royaume-Uni (8 aut., 15 aut., 16 aut.); Dean's Department, Dunedin School of Medicine, University of Otago/Dunedin/Nouvelle-Zélande (9 aut.); Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago/Dunedin/Nouvelle-Zélande (9 aut.); Division of Epidemiology/Clinical Research, Masonic Cancer Center, University of Minnesota/Minneapolis, MN/Etats-Unis (10 aut.); Department of Pediatrics, Masonic Cancer Center, University of Minnesota/Minneapolis, MN/Etats-Unis (10 aut.); National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Ministry of Health/Rio de Janeiro/Brésil (11 aut.); INSERM U1018, CESP Villejuif/France (12 aut., 13 aut., 21 aut.); Université Paris-Sud, UMRS 1018/Villejuif/France (12 aut., 13 aut., 21 aut.); National Registry of Childhood Hematopoietic Malignancies/Villejuif/France (13 aut., 21 aut.); German Childhood Cancer Registry at the Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg-University Mainz/Mainz/Allemagne (17 aut.); Department of Pediatric Hematology-Oncology, "Pan.&Agl. Kyriakou" Children's Hospital/Athens/Grèce (18 aut.); Sydney School of Public Health, University of Sydney/NSW/Australie (20 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>International journal of cancer : (Print); ISSN 0020-7136; Coden IJCNAW; Etats-Unis; Da. 2013; Vol. 133; No. 12; Pp. 2968-2979; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<EA>Positive associations have been reported between the measures of accelerated fetal growth and risk of childhood acute lymphoblastic leukemia (ALL). We investigated this association by pooling individual-level data from 12 case-control studies participating in the Childhood Leukemia International Consortium. Two measures of fetal growth-weight-for-gestational-age and proportion of optimal birth weight (POBW)-were analysed. Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, and combined in fixed effects meta-analyses. Pooled analyses of all data were also undertaken using multivariable logistic regression. Subgroup analyses were undertaken when possible. Data on weight for gestational age were available for 7,348 cases and 12,489 controls from all 12 studies and POBW data were available for 1,680 cases and 3,139 controls from three studies. The summary ORs from the meta-analyses were 1.24 (95% CI: 1.13, 1.36) for children who were large for gestational age relative to appropriate for gestational age, and 1.16 (95% CI: 1.09, 1.24) for a one-standard deviation increase in POBW. The pooled analyses produced similar results. The summary and pooled ORs for small-for-gestational-age children were 0.83 (95% CI: 0.75, 0.92) and 0.86 (95% CI: 0.77, 0.95), respectively. Results were consistent across subgroups defined by sex, ethnicity and immunophenotype, and when the analysis was restricted to children who did not have high birth weight. The evidence that accelerated fetal growth is associated with a modest increased risk of childhood ALL is strong and consistent with known biological mechanisms involving insulin-like growth factors.</EA>
<CC>002B04; 002B19B</CC>
<FD>Foetus; Croissance; Enfant; Leucémie aiguë lymphoblastique; Poids naissance; Métaanalyse; Cancérologie</FD>
<FG>Homme; Hémopathie maligne; Cancer; Syndrome lymphoprolifératif</FG>
<ED>Fetus; Growth; Child; Acute lymphocytic leukemia; Birth weight; Metaanalysis; Cancerology</ED>
<EG>Human; Malignant hemopathy; Cancer; Lymphoproliferative syndrome</EG>
<SD>Feto; Crecimiento; Niño; Leucemia aguda linfoblástica; Peso nacimiento; Meta-análisis; Cancerología</SD>
<LO>INIST-13027.354000501579740220</LO>
<ID>13-0338338</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000758 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000758 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0338338
   |texte=   Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium

Fetal growth and childhood acute lymphoblastic leukemia: Findings from the childhood leukemia international consortium

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri